rs727504859
Variant summary
Our verdict is Uncertain significance. The variant received 2 ACMG points: 3P and 1B. PM2PP5BP4
The NM_001134363.3(RBM20):c.2746G>A(p.Glu916Lys) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_001134363.3 missense
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1DDInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, G2P
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RBM20 | NM_001134363.3 | c.2746G>A | p.Glu916Lys | missense_variant | Exon 11 of 14 | ENST00000369519.4 | NP_001127835.2 | |
RBM20 | XM_017016103.3 | c.2581G>A | p.Glu861Lys | missense_variant | Exon 11 of 14 | XP_016871592.1 | ||
RBM20 | XM_017016104.3 | c.2362G>A | p.Glu788Lys | missense_variant | Exon 11 of 14 | XP_016871593.1 | ||
RBM20 | XM_047425116.1 | c.2362G>A | p.Glu788Lys | missense_variant | Exon 11 of 14 | XP_047281072.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Primary dilated cardiomyopathy Pathogenic:1
The Glu916Lys variant in RBM20 has been identified by our laboratory in 1 indivi dual with DCM was found to segregate with disease in 5 affected individuals, inc luding 4 obligate carriers. This variant was was absent from large population s tudies. Computational prediction tools and conservation analysis do not provide strong support for or against an impact to the protein. While pathogenic variant s in RBM20 have been reported in cases of DCM within exon 9 (Brauch 2009, Li 201 0), the impact of variants in other regions is currently unclear. In summary, al though additional studies are required to fully establish its clinical significa nce, the segregation with and presentation of disease in this family support tha t the Glu916Lys variant is likely pathogenic. -
Dilated cardiomyopathy 1DD Uncertain:1
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 916 of the RBM20 protein (p.Glu916Lys). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with RBM20-related conditions. ClinVar contains an entry for this variant (Variation ID: 179425). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RBM20 protein function. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at